Dataset Information

?-Adrenergic regulation of cardiac type 2A protein phosphatase through phosphorylation of regulatory subunit B56? at S573.

ABSTRACT: BACKGROUND:Type 2A protein phosphatase (PP2A) enzymes are serine/threonine phosphatases which comprise a scaffold A subunit, a regulatory B subunit and a catalytic C subunit, and have been implicated in the dephosphorylation of multiple cardiac phosphoproteins. B subunits determine subcellular targeting, substrate specificity and catalytic activity, and can themselves be regulated by post-translational modifications. We explored potential ?-adrenergic regulation of PP2A in cardiomyocytes through phosphorylation of the regulatory B subunit isoform B56?. METHODS AND RESULTS:Phosphate affinity SDS-PAGE and immunoblot analysis revealed increased phosphorylation of B56? in adult rat ventricular myocytes (ARVM) exposed to the ?-adrenergic receptor (?AR) agonist isoprenaline (ISO). Phosphorylation of B56? occurred at S573, primarily through stimulation of the ?1AR subtype, and was dependent on PKA activity. The functional role of the phosphorylation was explored in ARVM transduced with adenoviruses expressing wild type (WT) or non-phosphorylatable (S573A) B56?, fused to GFP at the N-terminus. C subunit expression was increased in ARVM expressing GFP-B56?-WT or GFP-B56?-S573A, both of which co-immunoprecipitated with endogenous C and A subunits. PP2A activity in cell lysates was increased in response to ISO in ARVM expressing GFP-B56?-WT but not GFP-B56?-S573A. Immunoblot analysis of the phosphoproteome in ARVM expressing GFP-B56?-WT or GFP-B56?-S573A with antibodies detecting (i) phospho-serine/threonine residues in distinct kinase substrate motifs or (ii) specific phosphorylated residues of functional importance in selected proteins revealed a comparable phosphorylation profile in the absence or presence of ISO stimulation. CONCLUSIONS:In cardiomyocytes, ?AR stimulation induces PKA-mediated phosphorylation of the PP2A regulatory subunit isoform B56? at S573, which increases associated PP2A catalytic activity. This is likely to regulate the phosphorylation status of specific B56?-PP2A substrates, which remain to be identified.

SUBMITTER: Ranieri A

PROVIDER: S-EPMC5823843 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

β-Adrenergic regulation of cardiac type 2A protein phosphatase through phosphorylation of regulatory subunit B56δ at S573.

Ranieri Antonella A Kemp Elizabeth E Burgoyne Joseph R JR Avkiran Metin M

Journal of molecular and cellular cardiology 20171230

<h4>Background</h4>Type 2A protein phosphatase (PP2A) enzymes are serine/threonine phosphatases which comprise a scaffold A subunit, a regulatory B subunit and a catalytic C subunit, and have been implicated in the dephosphorylation of multiple cardiac phosphoproteins. B subunits determine subcellular targeting, substrate specificity and catalytic activity, and can themselves be regulated by post-translational modifications. We explored potential β-adrenergic regulation of PP2A in cardiomyocytes ...[more]

PMID: 29294329

Similar Datasets

Project description:AimsB56α is a protein phosphatase 2A (PP2A) regulatory subunit that is highly expressed in the heart. We previously reported that cardiomyocyte B56α localizes to myofilaments under resting conditions and translocates to the cytosol in response to acute β-adrenergic receptor (β-AR) stimulation. Given the importance of reversible protein phosphorylation in modulating cardiac function during sympathetic stimulation, we hypothesized that loss of B56α in mice with targeted disruption of the gene encoding B56α (Ppp2r5a) would impact on cardiac responses to β-AR stimulation in vivo.Methods and resultsCardiac phenotype of mice heterozygous (HET) or homozygous (HOM) for the disrupted Ppp2r5a allele and wild type (WT) littermates was characterized under basal conditions and following acute β-AR stimulation with dobutamine (DOB; 0.75 mg/kg i.p.) or sustained β-AR stimulation by 2-week infusion of isoproterenol (ISO; 30 mg/kg/day s.c.). Left ventricular (LV) wall thicknesses, chamber dimensions and function were assessed by echocardiography, and heart tissue collected for gravimetric, histological, and biochemical analyses. Western blot analysis revealed partial and complete loss of B56α protein in hearts from HET and HOM mice, respectively, and no changes in the expression of other PP2A regulatory, catalytic or scaffolding subunits. PP2A catalytic activity was reduced in hearts of both HET and HOM mice. There were no differences in the basal cardiac phenotype between genotypes. Acute DOB stimulation induced the expected inotropic response in WT and HET mice, which was attenuated in HOM mice. In contrast, DOB-induced increases in heart rate were unaffected by B56α deficiency. In WT mice, ISO infusion increased LV wall thicknesses, cardiomyocyte area and ventricular mass, without LV dilation, systolic dysfunction, collagen deposition or foetal gene expression. The hypertrophic response to ISO was blunted in mice deficient for B56α.ConclusionThese findings identify B56α as a potential regulator of cardiac structure and function during β-AR stimulation.

Dataset Information

?-Adrenergic regulation of cardiac type 2A protein phosphatase through phosphorylation of regulatory subunit B56? at S573.

Publications

β-Adrenergic regulation of cardiac type 2A protein phosphatase through phosphorylation of regulatory subunit B56δ at S573.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets